Literature DB >> 15090992

Endothelial cell apoptosis in sepsis: a case of habeas corpus?

Richard S Hotchkiss, Irene E Karl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15090992     DOI： 10.1097/01.ccm.0000115264.93926.ec

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  6 in total

1.  Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways.

Authors:  Daniela Bermpohl; Annett Halle; Dorette Freyer; Emilie Dagand; Johann S Braun; Ingo Bechmann; Nicolas W J Schröder; Joerg R Weber
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

Review 2.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

3.  Biomarkers of endothelial cell activation in early sepsis.

Authors:  Simon Skibsted; Alan E Jones; Michael A Puskarich; Ryan Arnold; Robert Sherwin; Stephen Trzeciak; Philipp Schuetz; William C Aird; Nathan I Shapiro
Journal:  Shock       Date:  2013-05       Impact factor: 3.454

Review 4.  T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression.

Authors:  Stephanie A Condotta; Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 5.  Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review.

Authors:  Katharine Xing; Srinivas Murthy; W Conrad Liles; Jeffrey M Singh
Journal:  Crit Care       Date:  2012-01-16       Impact factor: 9.097

6.  High lncRNA MEG3 expression is associated with high mortality rates in patients with sepsis and increased lipopolysaccharide-induced renal epithelial cell and cardiomyocyte apoptosis.

Authors:  Kang Chen; Xiaojun Shi; Ye Jin; Feng Wang; Qing Shen; Weiming Xu
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.